[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100340314":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":29,"locations":38,"responsibleParty":107,"collaborators":11,"id":111,"slug":11,"hasResults":112,"nctId":113,"briefTitle":114,"officialTitle":114,"acronym":115,"eligibilityCriteria":116,"healthyVolunteers":112,"sex":117,"minAge":118,"maxAge":11,"enrollmentInfo":119,"targetDuration":11,"studyType":122,"phases":123,"briefSummary":125,"conditions":126,"keywords":11,"overallStatus":41,"whyStopped":11,"lastUpdateSubmitDate":132,"lastUpdatePostDateStruct":133,"startDateStruct":136,"completionDateStruct":138,"leadSponsor":140,"locationsCount":141},{"fullName":5,"class":6},"Hospital District of Helsinki and Uusimaa","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention","EXPERIMENTAL",null,[13,14],"Diagnostic Test: ECG monitoring for 3 weeks","Other: Self-monitoring of BP and self-titration of antihypertensive medication",{"label":16,"type":17,"description":18,"interventionNames":11},"Control","NO_INTERVENTION","Standard diagnostic work-up, follow-up, and treatment of hypertension.",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DIAGNOSTIC_TEST","ECG monitoring for 3 weeks","A 3-week continuous ECG monitoring to detect occult AF.",[9],{"type":6,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"Self-monitoring of BP and self-titration of antihypertensive medication","One-week monthly self-monitoring of BP and self-titration of antihypertensive medication according to a pre-specified protocol, assisted with a mobile device application.",[9],[30,35],{"name":31,"role":32,"phone":33,"phoneExt":11,"email":34},"Tuomas Lumikari, MD","CONTACT","+35894711","tuomas.lumikari@helsinki.fi",{"name":36,"role":32,"phone":11,"phoneExt":11,"email":37},"Anu Eräkanto","anu.erakanto@hus.fi",[39,57,77,92],{"facility":40,"status":41,"city":42,"state":11,"zip":11,"country":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Kanta-Häme Central Hospital","RECRUITING","Hämeenlinna","Finland",{"type":45,"coordinates":46},"Point",[47,48],24.46434,60.99596,{"lat":48,"lon":47},[51,54],{"name":52,"role":32,"phone":11,"phoneExt":11,"email":53},"Tiina Alapirtti, MD, PhD","tiina.alapirtti@khshp.fi",{"name":55,"role":32,"phone":11,"phoneExt":11,"email":56},"Elina Laakso, MD","elina.laakso@khshp.fi",{"facility":58,"status":41,"city":59,"state":11,"zip":60,"country":43,"cosmosGeoPoint":61,"geoPoint":65,"contacts":66},"Helsinki University Hospital","Helsinki","00290",{"type":45,"coordinates":62},[63,64],24.93545,60.16952,{"lat":64,"lon":63},[67,70,73,75],{"name":68,"role":32,"phone":33,"phoneExt":11,"email":69},"Terhi Saarikoski, RN","terhi.saarikoski@hus.fi",{"name":71,"role":72,"phone":11,"phoneExt":11,"email":11},"Tuomo Nieminen, Prof.","PRINCIPAL_INVESTIGATOR",{"name":74,"role":72,"phone":11,"phoneExt":11,"email":11},"Jukka Putaala, A\u002FProf.",{"name":31,"role":76,"phone":11,"phoneExt":11,"email":11},"SUB_INVESTIGATOR",{"facility":78,"status":41,"city":79,"state":11,"zip":11,"country":43,"cosmosGeoPoint":80,"geoPoint":84,"contacts":85},"Hyvinkää Hospital","Hyvinkää",{"type":45,"coordinates":81},[82,83],24.86667,60.63333,{"lat":83,"lon":82},[86,89],{"name":87,"role":32,"phone":11,"phoneExt":11,"email":88},"Terttu Heinkinheimo-Connell, MD, PhD","terttu.heikinheimo-connell@hus.fi",{"name":90,"role":32,"phone":11,"phoneExt":11,"email":91},"Katariina Hirvonen, MD","katariina.hirvonen@hus.fi",{"facility":93,"status":41,"city":94,"state":11,"zip":11,"country":43,"cosmosGeoPoint":95,"geoPoint":99,"contacts":100},"Päijät-Häme Central Hospital","Lahti",{"type":45,"coordinates":96},[97,98],25.66151,60.98267,{"lat":98,"lon":97},[101,104],{"name":102,"role":32,"phone":11,"phoneExt":11,"email":103},"Tuomo Nieminen, MD, PhD, Prof.","tuomo.nieminen@gmail.com",{"name":105,"role":32,"phone":11,"phoneExt":11,"email":106},"Anne Kerola, MD, PhD","anne.m.kerola@phhyky.fi",{"type":108,"investigatorFullName":109,"investigatorTitle":110,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"SPONSOR_INVESTIGATOR","Jukka Putaala","Head of Stroke Unit","100340314",false,"NCT03710902","Empowerment and Mobile Technology in the Control of Cardiovascular Risk Factors in Patients With Ischemic Stroke","CARDIOSTROKE","Inclusion Criteria:\n\n* Ischemic stroke or transient ischemic attack (ABCD2 score ≥3)\n* Age ≥40 years\n* Pre-existing or newly diagnosed hypertension\n* Informed consent from the patient or legal representative\n\nExclusion Criteria:\n\n* Known high-risk source of cardioembolism\n* Known indication for anticoagulation\n* Contraindication for anticoagulation\n* Pacemaker\n* Non-compliance to study interventions as judged by the investigator\n* Serious condition hampering the study conduct","ALL","40 Years",{"count":120,"type":121},405,"ESTIMATED","INTERVENTIONAL",[124],"NA","The CARDIOSTROKE is a randomized trial comparing mobile-device assisted control of hypertension together with screening of occult atrial fibrillation to standard care in patients with recent ischemic stroke or transient ischemic attack.",[127,128,129,130,131],"Ischemic Stroke","Transient Ischemic Attack","Atrial Fibrillation","Hypertension","Empowerment","2025-03-18",{"date":134,"type":135},"2025-03-20","ACTUAL",{"date":137,"type":135},"2018-10-17",{"date":139,"type":121},"2028-09",{"name":109,"class":6},4]